Speakers

Phil Morton

Chief Technology Officer • Albumedix

Dr. Philip Morton has a strong technology background with over 25 years’ experience in the biopharmaceutical industry within process and product development as well as product application research. He was trained as a biochemical engineer and has biopharmaceutical experience in both R&D and manufacturing environments in Albumedix under its former owners of Delta Biotechnology, Aventis and Novozymes. With his experience Phil brings a strong technological leadership to Albumedix.

Also Speaking

Image

Lior Raviv

Chief Technical Officer • Pluri
31 October 2022
Image

Leela Paris

Vice President, Process Engineering and Manufacturing, VCGT CMC Cell Manufacturing, • Vertex Cell and Gene Therapies
12 November 2022
Image

Benoit Bossuge

Head of Strategic Sourcing • CRISPR Therapeutics
26 October 2022

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
21 March 2023
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023